China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Efficacy Evaluation of ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133314
Registration Time: 2026/09/24
Type: Interventional study
Primary Sponsor: The Second Affiliated Hospital of the Army Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345086
Published by HT Digital Content Services with permission from Health Daily Digest....